These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


626 related items for PubMed ID: 28657745

  • 21. Rational Design of Drugs Targeting G-Protein-Coupled Receptors: Ligand Search and Screening.
    Luginina AP, Khnykin AN, Khorn PA, Moiseeva OV, Safronova NA, Pospelov VA, Dashevskii DE, Belousov AS, Borschevskiy VI, Mishin AV.
    Biochemistry (Mosc); 2024 May; 89(5):958-972. PubMed ID: 38880655
    [Abstract] [Full Text] [Related]

  • 22. Advances in Computational Techniques to Study GPCR-Ligand Recognition.
    Ciancetta A, Sabbadin D, Federico S, Spalluto G, Moro S.
    Trends Pharmacol Sci; 2015 Dec; 36(12):878-890. PubMed ID: 26538318
    [Abstract] [Full Text] [Related]

  • 23. Structure versus function-The impact of computational methods on the discovery of specific GPCR-ligands.
    Bermudez M, Wolber G.
    Bioorg Med Chem; 2015 Jul 15; 23(14):3907-12. PubMed ID: 25828056
    [Abstract] [Full Text] [Related]

  • 24. Established and In-trial GPCR Families in Clinical Trials: A Review for Target Selection.
    Saikia S, Bordoloi M, Sarmah R.
    Curr Drug Targets; 2019 Jul 15; 20(5):522-539. PubMed ID: 30394207
    [Abstract] [Full Text] [Related]

  • 25. Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts.
    Wold EA, Chen J, Cunningham KA, Zhou J.
    J Med Chem; 2019 Jan 10; 62(1):88-127. PubMed ID: 30106578
    [Abstract] [Full Text] [Related]

  • 26. Structural Basis for G Protein-Coupled Receptor Activation.
    Manglik A, Kruse AC.
    Biochemistry; 2017 Oct 24; 56(42):5628-5634. PubMed ID: 28967738
    [Abstract] [Full Text] [Related]

  • 27. Understanding the GPCR biased signaling through G protein and arrestin complex structures.
    Zhou XE, Melcher K, Xu HE.
    Curr Opin Struct Biol; 2017 Aug 24; 45():150-159. PubMed ID: 28558341
    [Abstract] [Full Text] [Related]

  • 28. Quantitative and systems pharmacology 2. In silico polypharmacology of G protein-coupled receptor ligands via network-based approaches.
    Wu Z, Lu W, Yu W, Wang T, Li W, Liu G, Zhang H, Pang X, Huang J, Liu M, Cheng F, Tang Y.
    Pharmacol Res; 2018 Mar 24; 129():400-413. PubMed ID: 29133212
    [Abstract] [Full Text] [Related]

  • 29. GPCR structures in drug design, emerging opportunities with new structures.
    Tautermann CS.
    Bioorg Med Chem Lett; 2014 Sep 01; 24(17):4073-9. PubMed ID: 25086683
    [Abstract] [Full Text] [Related]

  • 30. Emerging concepts of guanine nucleotide-binding protein-coupled receptor (GPCR) function and implications for high throughput screening.
    Eglen RM, Bosse R, Reisine T.
    Assay Drug Dev Technol; 2007 Jun 01; 5(3):425-51. PubMed ID: 17638542
    [Abstract] [Full Text] [Related]

  • 31. New insights from structural biology into the druggability of G protein-coupled receptors.
    Mason JS, Bortolato A, Congreve M, Marshall FH.
    Trends Pharmacol Sci; 2012 May 01; 33(5):249-60. PubMed ID: 22465153
    [Abstract] [Full Text] [Related]

  • 32. Structure-based and fragment-based GPCR drug discovery.
    Andrews SP, Brown GA, Christopher JA.
    ChemMedChem; 2014 Feb 01; 9(2):256-75. PubMed ID: 24353016
    [Abstract] [Full Text] [Related]

  • 33. Emerging structural insights into biased GPCR signaling.
    Shukla AK, Singh G, Ghosh E.
    Trends Biochem Sci; 2014 Dec 01; 39(12):594-602. PubMed ID: 25458114
    [Abstract] [Full Text] [Related]

  • 34. A Molecular Pharmacologist's Guide to G Protein-Coupled Receptor Crystallography.
    Piscitelli CL, Kean J, de Graaf C, Deupi X.
    Mol Pharmacol; 2015 Sep 01; 88(3):536-51. PubMed ID: 26152196
    [Abstract] [Full Text] [Related]

  • 35. Ligand-based homology modeling as attractive tool to inspect GPCR structural plasticity.
    Moro S, Deflorian F, Bacilieri M, Spalluto G.
    Curr Pharm Des; 2006 Sep 01; 12(17):2175-85. PubMed ID: 16796562
    [Abstract] [Full Text] [Related]

  • 36. Emerging opportunities for allosteric modulation of G-protein coupled receptors.
    Wang CI, Lewis RJ.
    Biochem Pharmacol; 2013 Jan 15; 85(2):153-62. PubMed ID: 22975406
    [Abstract] [Full Text] [Related]

  • 37. Toward fluorescent probes for G-protein-coupled receptors (GPCRs).
    Ma Z, Du L, Li M.
    J Med Chem; 2014 Oct 23; 57(20):8187-203. PubMed ID: 24983484
    [Abstract] [Full Text] [Related]

  • 38. G-protein coupled receptor structure.
    Yeagle PL, Albert AD.
    Biochim Biophys Acta; 2007 Apr 23; 1768(4):808-24. PubMed ID: 17097603
    [Abstract] [Full Text] [Related]

  • 39. The structure and dynamics of GPCR oligomers: a new focus in models of cell-signaling mechanisms and drug design.
    Filizola M, Weinstein H.
    Curr Opin Drug Discov Devel; 2005 Sep 23; 8(5):577-84. PubMed ID: 16159019
    [Abstract] [Full Text] [Related]

  • 40. Chemical Diversity in the G Protein-Coupled Receptor Superfamily.
    Vass M, Kooistra AJ, Yang D, Stevens RC, Wang MW, de Graaf C.
    Trends Pharmacol Sci; 2018 May 23; 39(5):494-512. PubMed ID: 29576399
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 32.